Astec Lifesciences (BOM:533138) Change In Payables And Accrued Expense : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Change In Payables And Accrued Expense?

Astec Lifesciences's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was ₹0 Mil. It means Astec Lifesciences's Accounts Payable & Accrued Expense stayed the same from Sep. 2024 to Dec. 2024 .

Astec Lifesciences's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0 Mil. It means Astec Lifesciences's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Astec Lifesciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Astec Lifesciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Change In Payables And Accrued Expense Chart

Astec Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Astec Lifesciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Astec Lifesciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Astec Lifesciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (BOM:533138) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

ASTEC:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.godrejastec.com

Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines